Adherium

Adherium Inventory

The Inventory of Adherium (ADR.AX) as of Oct 28, 2026 is 1.23 M AUD. In the previous year, Inventory was 1.84 M AUD — a change of -33.09% (lower).

Inventory

1.23 MAUD

YoY

-33.09%

Last updated:

Inventory of Adherium is 2026 1.23 M AUD. Inventory of Adherium was 2025 1.84 M AUD. It decreases by -33.09% lower compared to the previous year.

The Adherium Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
336,729.53 AUD
Jan 1, 2020
904,405.40 AUD
Jan 1, 2021
776,819.65 AUD
Jan 1, 2022
864,837.70 AUD
Jan 1, 2023
1.24 M AUD
Jan 1, 2024
1.58 M AUD
Jan 1, 2025
1.84 M AUD
Jan 1, 2026
1.23 M AUD
The Adherium Inventory history
YEARInventoryYoY
1.23 MAUD-33.09%
1.84 MAUD+16.18%
1.58 MAUD+27.71%
1.24 MAUD+43.26%
864,837.70AUD+11.33%
776,819.65AUD-14.11%
904,405.40AUD+168.59%
336,729.53AUD-18.07%
411,019.98AUD-29.89%
586,248.50AUD+73.68%
337,537.02AUD-56.86%
782,472.20AUD+407.33%
154,233.43AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adherium Stock analysis

What does Adherium do? Adherium Ltd develops and supplies connected medical devices and respiratory medications for patients, pharmaceutical companies, healthcare providers, and contract research organizations. The company generates revenue through its Hailie sensor technology and cloud-based data platform, which provides real-time feedback on patients' use of inhaled medication. The Hailie Remote Patient Management (RPM) Solution, Hailie Sensors, and Hailie Solution are key products sold to healthcare providers, payers, and pharmaceutical companies. These solutions enable optimal management of severe asthma and COPD, reduce healthcare costs, and offer remote monitoring capabilities for patients and physicians. The Hailie Sensor technology wraps around inhalers and connects via Bluetooth to capture medication use data, which is transmitted to the cloud-based Hailie platform. This platform delivers real-time feedback to patients through the Hailie app and to physicians via the Hailie portal. The company's focus on patient medication adherence and remote monitoring drives demand from healthcare providers seeking to improve treatment outcomes and from pharmaceutical companies aiming to enhance patient engagement with their respiratory medications. Adherium's products target segments including patients with severe asthma and COPD, healthcare providers managing chronic conditions, payers interested in cost reduction, and pharmaceutical companies developing respiratory medications. The company's revenue model centers on selling its sensor technology, cloud platform access, and integrated RPM solutions to these key segments, leveraging FDA-cleared devices to ensure compliance and reliability in healthcare settings. Adherium is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Adherium stock

Inventory of Adherium is 1.23 M AUD in 2026.

Inventory of Adherium changed from 1.84 M AUD to 1.23 M AUD, representing a -33.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Adherium since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Adherium historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Adherium

All Key Metrics — Adherium